PALSONIFY

Product NDC
84015-920
11-digit product format
840150920
Labeler code
84015
Product ID
84015-920_73db4875-9ff1-4eaf-bc83-0e494aada598
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
PALTUSOTINE
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Crinetics Pharmaceuticals, Inc.
Application
NDA219070
Marketing category
NDA
Marketing start
2025-09-25
Substance
PALTUSOTINE HYDROCHLORIDE
Active strength
20 mg/1
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
PALSONIFY
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PALTUSOTINE HYDROCHLORIDE20 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiFZT5Z83JNS
Rxcui2724403, 2724409, 2724411, 2724413

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84015-920-60PALSONIFY60 in 1 BOTTLETABLET, FILM COATED603

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2724409Palsonify 20 MG Oral Tablet, Once DailyPSN8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724413Palsonify 30 MG Oral Tablet, Once DailyPSN8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724403paltusotine 20 MG Oral Tablet, Once DailyPSN8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724411paltusotine 30 MG Oral Tablet, Once DailyPSN8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724409paltusotine 20 MG Oral Tablet [Palsonify]SBD8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724413paltusotine 30 MG Oral Tablet [Palsonify]SBD8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724403paltusotine 20 MG Oral TabletSCD8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724411paltusotine 30 MG Oral TabletSCD8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724409Palsonify 20 MG (equivalent to paltusotine hydrochloride 21.6 MG) Oral TabletSY8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724409Palsonify 20 MG Oral TabletSY8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724413Palsonify 30 MG (equivalent to paltusotine hydrochloride 32.4 MG) Oral TabletSY8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724413Palsonify 30 MG Oral TabletSY8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724403paltusotine 20 MG (equivalent to paltusotine hydrochloride 21.6 MG) Oral TabletSY8a6d2ce0-a621-4ee7-983c-977cd948ff4d3
2724411paltusotine 30 MG (equivalent to paltusotine hydrochloride 32.4 MG) Oral TabletSY8a6d2ce0-a621-4ee7-983c-977cd948ff4d3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
84015-920-608401509206060 TABLET, FILM COATED in 1 BOTTLE (84015-920-60) 2025-09-25NoNoCurrent